|
|
||||||||
EDUCATION EXHIBIT |
1 From the Department of Diagnostic Radiology, Faculty of Medicine, Cairo University-Kasr Al Ainy Hospital, 4 St 49 Mokattam, Cairo 11451, Egypt (S.N.S.); the Department of Diagnostic Radiology, Faculty of Medicine, Beny-Suif University, Beny-Suif, Egypt (A-H.M.S.); and the Department of Diagnostic Radiology, London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada (D.H.L.). Recipient of a Certificate of Merit award for an education exhibit at the 2005 RSNA Annual Meeting. Received June 23, 2006; revision requested September 7 and received October 16; accepted October 18. All authors have no financial relationships to disclose. Address correspondence to S.N.S. (e-mail: saharsaleem1{at}gmail.com).
The hypothalamus is susceptible to involvement by a variety of processes, including developmental abnormalities, primary tumors of the central nervous system (CNS), vascular tumors, systemic tumors affecting the CNS, and inflammatory and granulomatous diseases. The hypothalamus may also be involved by lesions arising from surrounding structures such as the pituitary gland. Magnetic resonance (MR) imaging is the modality of choice for evaluating the anatomy and pathologic conditions of the hypothalamus. The MR imaging differential diagnosis depends on accurate anatomic localization and tissue characterization of hypothalamic lesions through the recognition of their signal intensity and contrast material enhancement patterns. Diffusion-weighted imaging and proton MR spectroscopy can be helpful in differentiating among various types of hypothalamic lesions. Key MR imaging features, in addition to the patients age and clinical findings at presentation, may be helpful in developing the differential diagnosis for lesions involving the hypothalamic region.
© RSNA, 2007
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOGRAPHICS | RADIOLOGY | RSNA JOURNALS ONLINE |